Associated Papers
Structure-energy-based predictions and network modelling of RASopathy and cancer missense mutations.
Kiel C et al.
Molecular Systems Biology, 2014
24803665 (PubMed )
Supplement: MSB-10-5-727-s13.xls › energies
Cardiofaciocutaneous syndrome in a mother and two sons with a MEK2 mutation.
Linden HC et al.
Clinical Dysmorphology, 2011
Genes, proteins and complexes: the multifaceted nature of FHL family proteins in diverse tissues.
Shathasivam T et al.
Journal of Cellular and Molecular Medicine, 2010
Kinase-activating and kinase-impaired cardio-facio-cutaneous syndrome alleles have activity during zebrafish development and are sensitive to small molecule inhibitors.
Anastasaki C et al.
Human Molecular Genetics, 2009
Spectrum of MEK1 and MEK2 gene mutations in cardio-facio-cutaneous syndrome and genotype-phenotype correlations.
Dentici ML et al.
European Journal of Human Genetics : Ejhg, 2009
Crystal structures of MEK1 binary and ternary complexes with nucleotides and inhibitors.
Fischmann TO et al.
Biochemistry, 2009
Biochemical characterization of novel germline BRAF and MEK mutations in cardio-facio-cutaneous syndrome.
Rodriguez-Viciana P et al.
Methods in Enzymology, 2008
Select a paper to view details